HCP Inc. (NYSE:HCP) shares fell 1.6% during mid-day trading on Thursday . The company traded as low as $36.66 and last traded at $36.82, with a volume of 1,367,605 shares changing hands. The stock had previously closed at $37.43.

A number of brokerages have issued reports on HCP. Mizuho reissued a “hold” rating on shares of HCP in a research report on Tuesday. BMO Capital Markets reaffirmed a “sell” rating on shares of HCP in a research report on Tuesday, May 10th. Jefferies Group raised shares of HCP from an “underperform” rating to a “hold” rating and upped their target price for the stock from $25.00 to $32.00 in a research report on Tuesday, May 10th. Zacks Investment Research raised shares of HCP from a “hold” rating to a “buy” rating and set a $40.00 target price on the stock in a research report on Tuesday, July 5th. Finally, Morgan Stanley downgraded shares of HCP from an “equal weight” rating to an “underweight” rating and set a $32.00 target price on the stock. in a research report on Wednesday, June 22nd. Six equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the stock. The company has an average rating of “Hold” and a consensus price target of $33.97.

The company’s 50 day moving average is $34.73 and its 200-day moving average is $33.85. The firm’s market capitalization is $17.26 billion.

HCP (NYSE:HCP) last posted its quarterly earnings data on Monday, May 9th. The real estate investment trust reported $0.69 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.69. The business earned $640.80 million during the quarter, compared to analysts’ expectations of $621.93 million. The firm’s quarterly revenue was up 4.9% compared to the same quarter last year. During the same quarter last year, the firm earned $0.79 earnings per share. On average, equities research analysts expect that HCP Inc. will post $2.78 earnings per share for the current fiscal year.

Other hedge funds have bought and sold shares of the company. Vanguard Group Inc. boosted its stake in HCP by 3.1% in the fourth quarter. Vanguard Group Inc. now owns 61,238,590 shares of the real estate investment trust’s stock worth $2,341,765,000 after buying an additional 1,813,634 shares during the period. SFE Investment Counsel boosted its stake in shares of HCP by 3.9% in the fourth quarter. SFE Investment Counsel now owns 231,010 shares of the real estate investment trust’s stock valued at $8,834,000 after buying an additional 8,715 shares during the last quarter. First Trust Advisors LP boosted its stake in shares of HCP by 11.9% in the fourth quarter. First Trust Advisors LP now owns 412,536 shares of the real estate investment trust’s stock valued at $15,775,000 after buying an additional 43,726 shares during the last quarter. Agran Libbie boosted its stake in shares of HCP by 10,073.6% in the fourth quarter. Agran Libbie now owns 24,472,696 shares of the real estate investment trust’s stock valued at $9,358,000 after buying an additional 24,232,146 shares during the last quarter. Finally, Private Advisor Group LLC boosted its stake in shares of HCP by 7.3% in the fourth quarter. Private Advisor Group LLC now owns 145,822 shares of the real estate investment trust’s stock valued at $5,576,000 after buying an additional 9,910 shares during the last quarter.

HCP, Inc (HCP) is a self-administered real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing, post-acute/skilled nursing, life science, medical office and hospital.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.